Sareum Holdings plc (AIM: SAR), the structure-based drug discovery and services business, is pleased to announce its financial results for the six month period ended 31 December 2004.
Business Highlights to date:
Dr Tim Mitchell, CEO of Sareum Holdings, said: "Our debut as a publicly quoted company has been a successful one. Since joining the AIM Market we have announced several collaborative and fee-for-service collaborations. Our business development activities are expanding, we have fully equipped laboratories in Cambridge and together with our strong cash position, I believe Sareum is well positioned for a healthy year ahead."
For further information please contact:
Sareum Holdings 01223 497700
Tim Mitchell, Chief Executive Officer
Buchanan Communications 020 7466 5000
Tim Anderson, Mark Court, Mary-Jane Johnson
Results available as PDF document: Financial Results 2004